Cargando…
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
AIM: Tauroursodeoxycholic acid (TUDCA) is a taurine conjugated form of ursodeoxycholic acid (UDCA) with higher hydrophility. To further evaluate the efficacy and safety of TUDCA for primary biliary cholangitis (PBC), we performed this study on Chinese patients. METHODS: 199 PBC patients were randoml...
Autores principales: | Ma, Hong, Zeng, Minde, Han, Ying, Yan, Huiping, Tang, Hong, Sheng, Jifang, Hu, Heping, Cheng, Liufang, Xie, Qing, Zhu, Youfu, Chen, Guofeng, Gao, Zhiliang, Xie, Wen, Wang, Jiyao, Wu, Shanming, Wang, Guiqiang, Miao, Xiaohui, Fu, Xiaoqing, Duan, Liping, Xu, Jie, Wei, Lai, Shi, Guangfeng, Chen, Chengwei, Chen, Minhu, Ning, Qin, Yao, Chen, Jia, Jidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134868/ https://www.ncbi.nlm.nih.gov/pubmed/27893675 http://dx.doi.org/10.1097/MD.0000000000005391 |
Ejemplares similares
-
Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015) -
Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected
por: Liu, Wei, et al.
Publicado: (2017) -
Primary sclerosing cholangitis with increased immunoglobulin G4 levels: A case report
por: Chen, Qing-Ling, et al.
Publicado: (2019) -
Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis
por: Wang, Zi-Long, et al.
Publicado: (2022) -
Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients
por: Wang, Zi-Long, et al.
Publicado: (2022)